Literature DB >> 19349716

Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model.

Hasan Bilgili1, Ali Kosar, Mevlut Kurt, Ibrahim K Onal, Hakan Goker, Ozge Captug, Ali Shorbagi, Mehmet Turgut, Murat Kekilli, Ozlem Kar Kurt, Serafettin Kirazli, Salih Aksu, Ibrahim C Haznedaroglu.   

Abstract

OBJECTIVE: The purpose of this study was to show the hemostatic effect of spray, solution and tampon forms of Ankaferd Blood Stopper (ABS), a unique medicinal plant extract historically used as a hemostatic agent in Turkish folklore medicine, in a porcine bleeding model.
MATERIALS AND METHODS: Two 1-year-old pigs were used as bleeding models for superficial and deep skin lacerations, grade II liver and spleen injuries, grade II saphenous vein injury and grade IV saphenous artery injury. Spray, solution or tampon forms of ABS were applied after continuing bleeding was confirmed. The primary outcome was time to hemostasis. Volume of blood loss was not measured. The pigs were euthanized at the end of the experiment.
RESULTS: Spray or direct application of ABS solution resulted in instant control of bleeding in superficial and deep skin lacerations as well as puncture wounds of the liver. A 40-second application of ABS tampon was sufficient to stop bleeding of skin lacerations, while 1.5- and 3.5-min applications were used to control hemorrhage from the saphenous vein and artery, respectively. No rebleeding was observed once hemostasis was achieved. However, repeated applications of ABS solution and tampon were only temporarily effective in the hemostasis of spleen injury.
CONCLUSIONS: The data showed that ABS was an effective hemostatic agent for superficial and deep skin lacerations and minor/moderate trauma injuries in a porcine bleeding model. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19349716     DOI: 10.1159/000204344

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  23 in total

1.  Effects of a topical hemostatic agent on an epistaxis model in rabbits.

Authors:  Hanifi Kurtaran; Nebil Ark; K Serife Ugur; Huseyin Sert; Akin Altug Ozboduroglu; Ali Kosar; Mehmet Gunduz
Journal:  Curr Ther Res Clin Exp       Date:  2010-04

2.  The effects of ankaferd blood stopper on the recovery process in an experimental oesophageal perforation model.

Authors:  Necla Gürbüz Sarıkaş; Tanzer Korkmaz; Nurettin Kahramansoy; Ali Kılıçgün; Çetin Boran; Güledal Boztaş
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

3.  Unpredicted effects of Ankaferd® on cartilage tissue.

Authors:  Cenk Evren; Mehmet Birol Uğur; Burhan Yıldırım; Sibel Bektaş; Volkan Bilge Yiğit; Fikret Çınar
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Comparison of microporous polysaccharide hemospheres and Ankaferd Blood Stopper in a rabbit epistaxis model.

Authors:  Veysel Yurttas; Murat Sereflican; Elçin Hakan Terzi; Gulzade Ozyalvaçlı; Hasan Kazaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-23       Impact factor: 2.503

5.  Ankaferd hemostat in the management of gastrointestinal hemorrhages.

Authors:  Yavuz Beyazit; Murat Kekilli; Ibrahim C Haznedaroglu; Ertugrul Kayacetin; Metin Basaranoglu
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

Review 6.  Role of hemostatic powders in the endoscopic management of gastrointestinal bleeding.

Authors:  Marco Bustamante-Balén; Gema Plumé
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

7.  Evaluation of a haemostatic agent in rabbits.

Authors:  Nesrin Turhan; Hasan Bilgili; Ozge Captug; Mevlut Kurt; Ali Shorbagi; Yavuz Beyazit; Ozlem Kar Kurt; Ali Kosar; Ibrahim Celalettin Haznedaroglu
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-10-02

8.  Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis.

Authors:  Aysenur Meric Teker; Arzu Yasemin Korkut; Volkan Kahya; Orhan Gedikli
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-13       Impact factor: 2.503

9.  Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures.

Authors:  Mevlut Kurt; Ibrahim Onal; Meral Akdogan; Murat Kekilli; Mehmet Arhan; Abdurrahim Sayilir; Erkin Oztas; Ibrahim Haznedaroglu
Journal:  Can J Gastroenterol       Date:  2010-06       Impact factor: 3.522

10.  Effects of folk medicinal plant extract Ankaferd Blood Stopper(®) in vital primary molar pulpotomy.

Authors:  E Yaman; F Görken; A Pinar Erdem; E Sepet; Z Aytepe
Journal:  Eur Arch Paediatr Dent       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.